Mankind Pharma (BOM:543904) Interest Coverage : 54.08 (As of Dec. 2023)

View and export this data going back to 2023. Start your Free Trial

What is Mankind Pharma Interest Coverage?

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income by its Interest Expense. Mankind Pharma's Operating Income for the three months ended in Dec. 2023 was ₹4,968 Mil. Mankind Pharma's Interest Expense for the three months ended in Dec. 2023 was ₹-92 Mil. Mankind Pharma's interest coverage for the quarter that ended in Dec. 2023 was 54.08. The higher the ratio, the stronger the company's financial strength is.

Good Sign:

Ben Graham prefers companies' interest coverage to be at least 5. Mankind Pharma Ltd has enough cash to cover all of its debt. Its financial situation is stable.

The historical rank and industry rank for Mankind Pharma's Interest Coverage or its related term are showing as below:

BOM:543904' s Interest Coverage Range Over the Past 10 Years
Min: 33.67 Med: 67 Max: 83.22
Current: 68.34

BOM:543904's Interest Coverage is ranked better than
75.7% of 683 companies
in the Drug Manufacturers industry
Industry Median: 12.1 vs BOM:543904: 68.34

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Mankind Pharma Interest Coverage Historical Data

The historical data trend for Mankind Pharma's Interest Coverage can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Note: For Interest Coverage, "No debt" indicates no long-term debt. An indication of "No Debt" does not necessarily mean that the company has no long-term debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.

* Premium members only.

Mankind Pharma Interest Coverage Chart

Mankind Pharma Annual Data

Trend

Mar20

Mar21

Mar22

Interest Coverage

67.00

83.22

33.67

Mankind Pharma Quarterly Data
	Mar20	Mar21	Dec21	Mar22	Jun22	Sep22	Dec22	Jun23	Sep23	Dec23
Interest Coverage	Get a 7-Day Free Trial					49.68	27.60	89.51	67.97	54.08

Competitive Comparison of Mankind Pharma's Interest Coverage

For the Drug Manufacturers - Specialty & Generic subindustry, Mankind Pharma's Interest Coverage, along with its competitors' market caps and Interest Coverage data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Mankind Pharma's Interest Coverage Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Mankind Pharma's Interest Coverage distribution charts can be found below:

* The bar in red indicates where Mankind Pharma's Interest Coverage falls into.

Mankind Pharma Interest Coverage Calculation

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense:

If Interest Expense is negative and Operating Income is positive, then

Interest Coverage

-1

Operating Income

Interest Expense

Else if Interest Expense is negative and Operating Income is negative, then

The company did not have earnings to cover the interest expense.

Else if Interest Expense is 0 and Long-Term Debt & Capital Lease Obligation is 0, then

The company had no debt ⁽¹⁾.

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Mankind Pharma's Interest Coverage for the fiscal year that ended in Mar. 2022 is calculated as

Here, for the fiscal year that ended in Mar. 2022, Mankind Pharma's Interest Expense was ₹-558 Mil. Its Operating Income was ₹18,781 Mil. And its Long-Term Debt & Capital Lease Obligation was ₹522 Mil.

Interest Coverage	=	-1	*	Operating Income (A: Mar. 2022 )	/	Interest Expense (A: Mar. 2022 )
	=	-1	*	18781.31	/	-557.8
	=	33.67

Mankind Pharma's Interest Coverage for the quarter that ended in Dec. 2023 is calculated as

Here, for the three months ended in Dec. 2023, Mankind Pharma's Interest Expense was ₹-92 Mil. Its Operating Income was ₹4,968 Mil. And its Long-Term Debt & Capital Lease Obligation was ₹0 Mil.

Interest Coverage	=	-1	*	Operating Income (Q: Dec. 2023 )	/	Interest Expense (Q: Dec. 2023 )
	=	-1	*	4967.796	/	-91.854
	=	54.08

The higher the ratio, the stronger the company's Financial Strength is.

Mankind Pharma (BOM:543904) Interest Coverage Explanation

Ben Graham requires that a company has a minimum interest coverage of 5 with the companies he invested. If the interest coverage is less than 2, the company is burdened by debt. Any business slow or recession may drag the company into a situation where it cannot pay the interest on its debt.

Interest Coverage is an important factor when GuruFocus ranks a company's overage Financial Strength .

Mankind Pharma Interest Coverage Related Terms

Thank you for viewing the detailed overview of Mankind Pharma's Interest Coverage provided by GuruFocus.com. Please click on the following links to see related term pages.

Mankind Pharma (BOM:543904) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Mankind Pharma Ltd (BOM:543904) » Definitions » Interest Coverage

Traded in Other Exchanges

MANKIND:India

Address

262, Okhla Industrial Estate, Phase-III, New Delhi, IND, 110020

Website

https://www.mankindpharma.com

Mankind Pharma Ltd is engaged in developing, manufacturing and marketing a diverse range of pharmaceutical formulations across various acute and chronic therapeutic areas, as well as several consumer healthcare products. It operates at the intersection of Indian pharmaceutical formulations and consumer healthcare sectors with the aim of providing quality products at affordable prices and has an established track record of building and scaling brands in-house. The company's brands include Manforce, Prega News and Gas-O-Fast.

Mankind Pharma (BOM:543904) Headlines

No Headlines